Microbiological Condition in Parodont Tissue in Law Enforcement Officers
Keywords:
gingivitis, periodontal microbiota, oral hygiene index, law enforcement officers, vacuum-laser therapy, KPO indexAbstract
Periodontal tissue diseases, particularly gingivitis, remain highly prevalent among occupational groups exposed to chronic psychological and physical stress, including law enforcement officers. This study aimed to assess the clinical, hygienic, and microbiological condition of periodontal tissues in law enforcement personnel and to evaluate the efficacy of a complex treatment protocol combining traditional therapy with vacuum-laser massage and phytotherapeutic adjuncts. A total of 145 officers underwent clinical dental examination, hygienic and caries-intensity indexing, quality-of-life questionnaires, and microbiological analysis of oral fluid and gingival-pocket exudate. Patients were divided into a traditional-treatment group (n=60) and a complex-treatment group (n=62) receiving additional oral hydromassage, herbal rinses, pomegranate seed oil application, and vacuum-laser therapy. Catarrhal gingivitis was diagnosed in 84.12% of cases, hypertrophic in 5.52%, and ulcerative in 10.34%. The KPO caries index was 17.94±0.23. Quantitative microbiological analysis revealed high titers of periodontopathogenic and conditionally pathogenic species, including B. gingivalis (7.29±0.28 log CFU/ml) and S. epidermidis (6.6±0.37 log CFU/ml). Following complex treatment, microbial counts of periodontopathogenic and cariogenic species decreased substantially compared with traditional treatment alone, and positive clinical dynamics were observed in 91.9% of cases. These findings support the integration of vacuum-laser and phytotherapeutic adjuncts into standard periodontal-care protocols for high-stress occupational populations.
References
[1] L. Trombelli, R. Farina, C. O. Silva, and D. N. Tatakis, “Plaque-induced gingivitis: Case definition and diagnostic considerations,” J. Clin. Periodontol., vol. 45, no. S20, pp. S44–S67, 2018.
[2] T. Berglundh, G. Armitage, M. G. Araujo, et al., “Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop,” J. Clin. Periodontol., vol. 45, no. S20, pp. S286–S291, 2018.
[3] P. M. Preshaw, A. L. Alba, D. Herrera, et al., “Periodontitis and diabetes: a two-way relationship,” Diabetologia, vol. 55, no. 1, pp. 21–31, 2012.
[4] S. Ceraulo, A. Barbarisi, G. Caccianiga, et al., “A possible correlation between periodontal disease and systemic diseases: A clinical study,” BMC Oral Health, vol. 26, art. 13, 2026.
[5] S. S. Socransky, A. D. Haffajee, M. A. Cugini, C. Smith, and R. L. Kent Jr., “Microbial complexes in subgingival plaque,” J. Clin. Periodontol., vol. 25, no. 2, pp. 134–144, 1998.
[6] G. Hajishengallis, R. P. Darveau, and M. A. Curtis, “The keystone-pathogen hypothesis,” Nat. Rev. Microbiol., vol. 10, no. 10, pp. 717–725, 2012.
[7] S. Ramlogan, V. Raman, K. Abraham, and K. Pierre, “Self-reported stress, coping ability, mental status, and periodontal diseases among police recruits,” Clin. Exp. Dent. Res., vol. 6, no. 1, pp. 117–123, 2020.
[8] World Health Organization, Oral Health Surveys: Basic Methods, 5th ed. Geneva, Switzerland: WHO Press, 2013.
[9] J. C. Greene and J. R. Vermillion, “The simplified oral hygiene index,” J. Am. Dent. Assoc., vol. 68, no. 1, pp. 7–13, 1964.
[10] G. D. Slade, “Derivation and validation of a short-form oral health impact profile,” Community Dent. Oral Epidemiol., vol. 25, no. 4, pp. 284–290, 1997.
[11] J. E. Ware Jr. and C. D. Sherbourne, “The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection,” Med. Care, vol. 30, no. 6, pp. 473–483, 1992.
[12] C. A. Somu, S. Ravindra, S. Ajith, and M. G. Ahmed, “Efficacy of a herbal extract gel in the treatment of gingivitis: A clinical study,” J. Ayurveda Integr. Med., vol. 3, no. 2, pp. 85–90, 2012.
[13] S. Dervisbegovic, S. Lettner, D. Tur, et al., “Adjunctive low-level laser therapy in periodontal treatment: a randomized clinical split-mouth trial,” Clin. Oral Investig., vol. 29, no. 5, art. 273, 2025.
[14] C.-M. Radu, C. C. Radu, and D. C. Zaha, “Salivary and microbiome biomarkers in periodontitis: Advances in diagnosis and therapy—A narrative review,” Medicina, vol. 61, no. 10, art. 1818, 2025.
[15] M. Sanz, D. Herrera, M. Kebschull, et al., “Treatment of stage I–III periodontitis—The EFP S3 level clinical practice guideline,” J. Clin. Periodontol., vol. 47, no. S22, pp. 4–60, 2020.
